Vasileios Lioutas
Overview
Explore the profile of Vasileios Lioutas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Incontri D, Marchina S, Wilson M, Wang J, Losso M, Andreev A, et al.
Eur Neurol
. 2025 Feb;
:1-7.
PMID: 39938483
Introduction: Cerebral small vessel disease (CSVD) is a major cause of primary lobar intracerebral hemorrhage (ICH) due to cerebral amyloid angiopathy (CAA) or hypertensive arteriopathy (HA). Sex differences in CSVD...
2.
Pinheiro A, Aparicio H, Lioutas V, Beiser A, Ekenze O, DeCarli C, et al.
medRxiv
. 2024 Nov;
PMID: 39606408
Background: Mild manifestations of individual cerebral small vessel disease (CSVD) markers are common and may not denote increased risk, but high CSVD burden identifies individuals at increased risk of stroke...
3.
de Souza A, Lioutas V, Sebastian I, Asyraf W, Amaya P, Rocha E, et al.
Stroke
. 2023 Jun;
54(8):e399-e402.
PMID: 37264914
No abstract available.
4.
Aponte Becerra L, Gavrieli A, Khan F, Novak P, Lioutas V, Ngo L, et al.
Clin Nutr
. 2023 Apr;
42(6):825-834.
PMID: 37084469
Centrally administered insulin stimulates the reward system to reduce appetite in response to food intake in animal studies. In humans, studies have shown conflicting results, with some studies suggesting that...
5.
Isaza-Pierrotti D, Khan F, Novak P, Lioutas V, Mantzoros C, Ngo L, et al.
Contemp Clin Trials
. 2022 Dec;
125:107057.
PMID: 36539060
Background: Effective recruitment and retention strategies are essential in clinical trials. Methods: The MemAID trial consisted of 12 visits during 24 weeks of intranasal insulin or placebo treatment and 24 ...
6.
Kumar S, Marchina S, Langmore S, Massaro J, Palmisano J, Wang N, et al.
Sci Rep
. 2022 Jun;
12(1):9607.
PMID: 35689084
Dysphagia is a serious stroke complication but lacks effective therapy. We investigated safety and preliminary efficacy of anodal transcranial direct current stimulation (atDCS) paired with swallowing exercises in improving post-stroke...
7.
Tarko L, Costa L, Galloway A, Ho Y, Gagnon D, Lioutas V, et al.
Neurology
. 2022 Jun;
98(24):e2465-e2473.
PMID: 35649728
Background And Objectives: Racial and ethnic disparities in stroke outcomes exist, but differences by stroke type are less understood. We studied the association of race and ethnicity with stroke mortality,...
8.
Novak V, Mantzoros C, Novak P, McGlinchey R, Dai W, Lioutas V, et al.
J Neurol
. 2022 Apr;
269(9):4817-4835.
PMID: 35482079
Background: This study aimed at assessing the long-term effects of intranasal insulin (INI) on cognition and gait in older people with and without type 2 diabetes mellitus (T2DM). Methods: Phase...
9.
Foster L, Robinson L, Yeatts S, Conwit R, Shehadah A, Lioutas V, et al.
Stroke
. 2022 Mar;
53(7):2204-2210.
PMID: 35306827
Background: There are limited data on the trajectory of recovery and long-term functional outcomes after intracerebral hemorrhage (ICH). Most ICH trials have conventionally assessed outcomes at 3 months following the...
10.
Goyal N, Tsivgoulis G, Malhotra K, Ishfaq M, Pandhi A, Frohler M, et al.
JAMA Neurol
. 2019 Sep;
77(1):16-24.
PMID: 31545353
Importance: The benefit of mechanical thrombectomy (MT) in patients with stroke presenting with mild deficits (National Institutes of Health Stroke Scale [NIHSS] score <6) owing to emergency large-vessel occlusion (ELVO)...